Mesa Air net loss narrows
(6:25 AM ET) LONDON (MarketWatch) -- U.S. airline Mesa Air Group Inc. (MESA:![]()
MESA 0.29, +0.01, +2.9%) said Tuesday that its fiscal fourth-quarter net loss narrowed to $30.6 million, or $1.15 a share, from $68.2 million, or $2.37 a share, a year earlier. Revenue for the quarter fell 0.8% to $325.3 million as a fall in capacity was partially offset by an increase in fuel revenue. Losses from continuing operations for the quarter were $22.3 million, or 83 cents a share. Pro forma net income, which excludes among other things the impact of vendor settlements, equity investments and a settlement with Aloha Airlines, rose 41% to $3.1 million.
Mesa Air Group Inc
Last: 0.29+0.01+2.86%
3:59pm 01/12/2009
Delayed quote data
3:59pm 01/12/2009
Delayed quote data
Sponsored by:
EADS CEO Gallois reiterates financial targets
(6:19 AM ET) NEWPORT, Wales (MarketWatch) -- European aerospace and defense giant and Airbus parent EADS (fr:FR:005730: news , chart , profile ) on Tuesday confirmed its financial targets for 2008. "None of our objectives are changed because of the economic crisis," EADS Chief Executive Louis Gallois said at a press conference. He stressed, however, that the top priority for the group at the moment is cash preservation and that the company doesn't plan to make a major acquisition in the current climate. Regarding Airbus, Gallois said EADS was ready to increase financing support to customers in order to protect deliveries in 2009. He also said that Airbus was ready to adjust production rates if necessary to avoid building inventories.
QLT says appeals court upholds patent ruling against firm
(3:37 AM ET) TEL AVIV (MarketWatch) -- QLT Inc., (QLTI:![]()
QLTI 2.46, -0.19, -7.2%) (ca:CA:QLT: news , chart , profile ) the Vancouver biopharmaceutical company focused on ophthalmology, said the U.S. Court of Appeals for the First Circuit affirmed a lower court's judgment against it in a patent case brought by Massachusetts Eye and Ear Infirmary. The court upheld a ruling from U.S. District Court for the District of Massachusetts in a case involving a patent and certain research results of the infirmary as they relate to QLT's Visudyne drug. QLT said it is considering whether to appeal the case further. The district court found QLT liable under Massachusetts state law for unfair trade practices and awarded the infirmary 3.01% of past, present and future sales of the drug, the company said. QLT estimates that it must pay the infirmary $113.2 million plus legal fees and interest. In addition, Massachusetts General Hospital is claiming higher payments from QLT based on the amounts QLT must pay the infirmary, a claim QLT said it disputes.
QLT Inc.
Last: 2.46-0.19-7.17%
4:00pm 01/12/2009
Delayed quote data
4:00pm 01/12/2009
Delayed quote data
Sponsored by:
Peugeot sales decline as market share holds steady
(2:35 AM ET) LONDON (MarketWatch) -- French car maker Peugeot (fr:FR:012150: news , chart , profile ) said Tuesday that its total sales of vehicles in completed and kit form in 2008 fell 4.9% to 3.26 million units. The group said its global market shares was maintained at 5% and its market share in Western Europe was steady at 13.8%, though total registrations in the region dropped 8.6% to 2.13 million units.
